Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Acquisitions (2016 - 2022)

Cross Country Healthcare's Acquisitions history spans 9 years, with the latest figure at $35.2 million for Q4 2022.

  • For Q4 2022, Acquisitions rose 905.2% year-over-year to $35.2 million; the TTM value through Dec 2022 reached $38.7 million, up 1005.2%, while the annual FY2022 figure was $35.2 million, 25.78% up from the prior year.
  • Acquisitions reached $35.2 million in Q4 2022 per CCRN's latest filing, up from $3.5 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $35.2 million in Q4 2022 to a low of $1.9 million in Q4 2018.
  • Average Acquisitions over 3 years is $13.5 million, with a median of $3.5 million recorded in 2021.
  • The largest YoY upside for Acquisitions was 905.2% in 2022 against a maximum downside of 905.2% in 2022.
  • A 3-year view of Acquisitions shows it stood at $1.9 million in 2018, then soared by 81.35% to $3.5 million in 2021, then soared by 905.2% to $35.2 million in 2022.
  • Per Business Quant, the three most recent readings for CCRN's Acquisitions are $35.2 million (Q4 2022), $3.5 million (Q4 2021), and $1.9 million (Q4 2018).